About SynHelix
SynHelix is a company based in Evry-courcouronnes (France) founded in 2019 by Ahmed Said and Irina Gbalou was acquired by Univercells in January 2022. SynHelix operates in a competitive market with competitors including Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.
- Headquarter Evry-courcouronnes, France
- Founders Ahmed Said, Irina Gbalou
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Univercells
(Jan 06, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SynHelix
Detailed funding history for SynHelix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in SynHelix
SynHelix has secured backing from 1 investor. Prominent investors backing the company include Univercells.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
Locked | Locked | Locked |
Investor details for SynHelix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SynHelix
Investment portfolio details for SynHelix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SynHelix
Detailed financials for SynHelix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synhelix Comparisons
Peer comparison for SynHelix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SynHelix
SynHelix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
DNA synthesis technology using enzymes is provided.
|
|
| Locked | Locked | Locked |
mRNA therapeutics are developed via proprietary biochip platforms.
|
|
| Locked | Locked | Locked |
Benchtop DNA printers for nucleic acid synthesis are developed.
|
|
| Locked | Locked | Locked |
Developer of mRNA technology for therapeutics and vaccines
|
Detailed competitors of SynHelix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synhelix
Complete news archive for SynHelix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SynHelix
SynHelix was founded in 2019.
SynHelix is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Irina Gbalou is the current CEO of SynHelix. They have also founded this company.
SynHelix was founded in 2019 in Evry Courcouronnes, France, within the biotechnology sector. An enzyme-based DNA synthesis solution is provided by the company, enabling gigaprep-scale production. This technology supports applications including cell and gene therapies, personalized diagnostics, and DNA vaccines. Operations focus on advancing DNA manufacturing processes for research and therapeutic uses.
SynHelix's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.
SynHelix has 1 investor. Key investors include Univercells.